xh-s003
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 19, 2023 (NCT05946876)
Timeline
Indications
Studied for
Mechanism of action
- Complement factor BINHIBITOR
CFB inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06978699 | Phase 2 | Apr 30, 2025 | Infinity Pharmaceuticals, Inc. |
| NCT06272747 | Phase 1 | Feb 22, 2024 | Infinity Pharmaceuticals, Inc. |
| NCT05946876 | Phase 1 | Jul 19, 2023 | Infinity Pharmaceuticals, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Infinity Pharmaceuticals, Inc. | For profit | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1